Jason S. Fisherman is Director at ACHILLION PHARMACEUTICALS INC (ACHN). They have made 10 open-market trades across 2 companies since 2010, most recently 2020-01-28.
CIK 0001197540
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $275K since 2010, against 4 sales. Across 6 scored buys the stock is down 4.2% at ninety days, and 5.0 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 17% | 0% | 0% |
| Avg Move | -21.3% | -3.1% | -4.2% |
| Alpha | -16.5% | -3.3% | -5.0% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACHN | BUY | 2016-12-22 | 2016-12-23 | $3.96 | $40K | +1.4% | -7.3% | -13.7% |
| ACHN | BUY | 2013-11-18 | 2013-11-20 | $2.63 | $40K | -25.7% | -1.9% | -1.9% |
| ACHN | BUY | 2013-08-14 | 2013-08-14 | $6.83 | $34K | -25.7% | -1.9% | -1.9% |
| ACHN | BUY | 2013-06-21 | 2013-06-25 | $7.63 | $76K | -25.7% | -1.9% | -1.9% |
| ACHN | BUY | 2013-06-03 | 2013-06-05 | $7.87 | $79K | -25.7% | -1.9% | -1.9% |
| ACHN | SELL | 2011-07-21 | 2011-07-22 | $7.96 | $995 | -25.7% | -1.9% | -1.9% |
| ACHN | SELL | 2011-07-18 | 2011-07-20 | $7.48 | $1K | -25.7% | -1.9% | -1.9% |
| ACHN | SELL | 2011-07-13 | 2011-07-15 | $7.72 | $4K | -25.7% | -1.9% | -1.9% |
| ACHN | SELL | 2011-07-08 | 2011-07-12 | $7.88 | $3K | -25.7% | -1.9% | -1.9% |
| AEGR | BUY | 2010-10-27 | 2010-10-27 | $9.50 | $7K | -26.4% | -3.7% | -3.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.